Soon we’ll not be supporting this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Lexagene Holdings Inc (LXG) NPV

Sell:0.48 CAD Buy:0.51 CAD Change: 0.075 CAD (17.65%)
Market closed |  Prices as at close on 16 September 2021 | Switch to live prices |
Sell:0.48 CAD
Buy:0.51 CAD
Change: 0.075 CAD (17.65%)
Market closed |  Prices as at close on 16 September 2021 | Switch to live prices |
Sell:0.48 CAD
Buy:0.51 CAD
Change: 0.075 CAD (17.65%)
Market closed |  Prices as at close on 16 September 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

LexaGene Holdings, Inc. is a Canada-based molecular diagnostics company. The Company develops genetic analyzers for pathogen detection and other molecular markers for on-site testing in veterinary diagnostics, food safety and for use in open-access markets, including clinical research, agricultural testing and biodefense. It offers MiQLab genetic analyzer. The MiQLab genetic analyzer offers automated pathogen detection and customized testing. The MiQLab genetic analyzer draws each liquid sample into a sample preparation cartridge, where microbes are concentrated and lysed before the genetic material is purified. Its analyzer pulls the purified genomic material from inside the cartridge into the system’s microfluidics where a series of real-time polymerase chain reaction (PCR) mixtures are assembled, multiplex quantitative polymerase chain reactions (qPCR) are amplified and the results are analyzed.

Contact details

Address:
500 Cummings Ctr Ste 4550
BEVERLY
01915-6534
United States
Telephone:
+1 (604) 6810084
Website:
lexagene.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
LXG
ISIN:
CA52886L1031
Market cap:
50.63 million CAD
Shares in issue:
119.12 million
Sector:
Health Care Equipment
Exchange:
Canadian Venture Exchange
Country:
Canada
Currency:
Canadian dollars
Indices:
n/a

Key personnel

  • John Regan
    Chairman of the Board, Chief Executive Officer
  • Jeffrey Mitchell
    Chief Financial Officer, Treasurer, Corporate Secretary
  • Steven Armstrong
    Director - Operations
  • Eleanor Kolossovski
    Director of Product Marketing

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.